Kevin Laliberte
Kevin Laliberte publishes mostly in Pulmonary and Respiratory Medicine, Cardiology and Cardiovascular Medicine and Molecular Biology, on topics such as Pulmonary Hypertension Research and Treatments, Heart Failure Treatment and Management and Phosphodiesterase function and regulation.
- World rank
- #1,835,795 of 7,710,434 ranked researchers
- Rank in United States
- #563,025 of 1,627,098
- Works
- 29
- Citations
- 1.6k
- Citations per work
- 55.4
What does Kevin Laliberte research?
Kevin Laliberte's work is mostly in Medicine (70%), Biochemistry, Genetics and Molecular Biology (8%), Pharmacology, Toxicology and Pharmaceutics (3%).
Their six largest subfields, inside their fields and domains; the grey slice is everything else they publish. The interactive view splits every one of their works down to single topics.
The fields and subfields, with their numbers
- Health Sciences2069.6%
- Medicine2069.6%
- Everything else620.3%
- Life Sciences310.1%
- 1Pulmonary and Respiratory Medicine35% of their works
- 2Cardiology and Cardiovascular Medicine24% of their works
- 3Molecular Biology8% of their works
- 4Hepatology6% of their works
- 5Physiology4% of their works
- 6Pharmacology2% of their works
Research topics
- Pulmonary Hypertension Research and Treatments
- Heart Failure Treatment and Management
- Phosphodiesterase function and regulation
- Liver Disease and Transplantation
- Cardiovascular Issues in Pregnancy
- Chronic Obstructive Pulmonary Disease (COPD) Research
- Cardiac Valve Diseases and Treatments
- Cardiovascular Function and Risk Factors
Which keywords describe Kevin Laliberte's research?
The keywords of their largest research topics: Echocardiography, Pulmonary Hypertension, Right Heart Assessment, Diagnosis, Heart Failure, Guidelines, Treatment and Management.
- Transcatheter Aortic-Valve Replacement
- Diastolic Function
- spirometry
- Cardiovascular Diseases
- Liver Cirrhosis
- cAMP Signaling
- Management
- Guidelines
- Diagnosis
- Pulmonary Hypertension
- Echocardiography
- Right Heart Assessment
- Heart Failure
- Treatment
- Cyclic Nucleotide Phosphodiesterases
- Hepatic Encephalopathy
- COPD
- Pregnancy
- Chamber Quantification
- Surgical Aortic-Valve Replacement
Size is their works in the topics tagged with each word, from their 8 largest topics. Each links to the topic it comes from most. The words come from the keyword list OpenAlex gives each topic, not from the text of the papers, so a word can appear that none of the papers uses.
All 20 words, with their numbers
- Echocardiography252 topics
- Pulmonary Hypertension231 topic
- Right Heart Assessment231 topic
- Diagnosis132 topics
- Heart Failure112 topics
- Guidelines91 topic
- Treatment91 topic
- Management82 topics
- Cyclic Nucleotide Phosphodiesterases61 topic
- cAMP Signaling61 topic
- Hepatic Encephalopathy51 topic
- Liver Cirrhosis51 topic
- COPD41 topic
- Cardiovascular Diseases41 topic
- Pregnancy41 topic
- spirometry41 topic
- Chamber Quantification21 topic
- Diastolic Function21 topic
- Surgical Aortic-Valve Replacement21 topic
- Transcatheter Aortic-Valve Replacement21 topic
Where does Kevin Laliberte work?
Kevin Laliberte's main affiliation in the publication record is United Therapeutics (United States), United States.
How many publications and citations does Kevin Laliberte have?
OpenAlex counts 29 works and 1,607 citations for Kevin Laliberte, an h-index of 13, ranking #1,835,795 of 7,710,434 researchers worldwide on the quality score.
Ranked on field-normalised citation excellence (50%), output (30%) and citations (20%). Counts come from OpenAlex author records, which occasionally merge different people who share a name or split one person into several.
Papers, co-authors, who cited this work and researchers on the nearest topics have tabs of their own, above. Is this your page? Claim it with your ORCID iD, or request a correction or removal.
Discussion
Ask a question or share a note about Kevin Laliberte. Keep it to the research: no personal attacks, advertising or links. Any reader can report a post, which collapses it for everyone until it is opened.